Neuren Pharmaceuticals Limited (ASX:NEU)
Australia · Delayed Price · Currency is AUD 13.20
-1.43 (-9.77%)
At close: Feb 5, 2026
Neuren Pharmaceuticals Market Cap
Neuren Pharmaceuticals has a market cap or net worth of 1.67 billion as of February 5, 2026. Its market cap has decreased by -3.23% in one year.
Market Cap
1.67B
Enterprise Value
1.37B
Revenue
218.86M
Ranking
n/a
PE Ratio
11.50
Stock Price
13.20
Market Cap Chart
Since February 3, 2005, Neuren Pharmaceuticals's market cap has increased from 20.93M to 1.67B, an increase of 7,888.13%. That is a compound annual growth rate of 23.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 1.85B | -21.39% |
| Dec 31, 2025 | 2.36B | 48.44% |
| Dec 31, 2024 | 1.59B | -50.04% |
| Dec 29, 2023 | 3.18B | 217.33% |
| Dec 30, 2022 | 1.00B | 110.88% |
| Dec 31, 2021 | 474.89M | 222.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 3.43B |
| Mesoblast | 3.21B |
| Clarity Pharmaceuticals | 1.04B |
| PYC Therapeutics | 880.72M |
| Opthea | 738.77M |
| Clinuvel Pharmaceuticals | 591.87M |
| Immutep | 567.38M |
| Racura Oncology | 415.62M |